Cargando…
Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
It remains uncertain whether the hypertension (HT) medications angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) mitigate or exacerbate SARS‐CoV‐2 infection. We evaluated the association of ACEi and ARB with severe coronavirus disease 19 (COVID‐19) as defined by...
Autores principales: | Bauer, Ann Z., Gore, Rebecca, Sama, Susan R., Rosiello, Richard, Garber, Lawrence, Sundaresan, Devi, McDonald, Anne, Arruda, Patricia, Kriebel, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753489/ https://www.ncbi.nlm.nih.gov/pubmed/33220171 http://dx.doi.org/10.1111/jch.14101 |
Ejemplares similares
-
Targeting patients for early COVID-19 therapy; Pre-infection metabolic dysfunction, polycystic ovary syndrome and risk of severe disease in patients under 65: A Massachusetts community-based observational study
por: Sama, Susan R., et al.
Publicado: (2023) -
A commentary on the impacts of ‘Great Lockdown’ and its aftermath on scaling firms: What are the implications for entrepreneurial research?
por: Greene, Francis J, et al.
Publicado: (2020) -
Environmental triggers of COPD symptoms: a case cross-over study
por: Sama, Susan R, et al.
Publicado: (2017) -
Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021) -
An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis
por: Wang, H.Y., et al.
Publicado: (2023)